What is the Impact Factor of CNS Neuroscience & Therapeutics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of CNS Neuroscience & Therapeutics is 6.60, ranking in quartile Q1 of Web of Science (SCIE).

Is CNS Neuroscience & Therapeutics indexed in Web of Science or Scopus?

Yes, CNS Neuroscience & Therapeutics is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.741 (Q1) and an H-index of 105.

Who publishes CNS Neuroscience & Therapeutics and what is the Article Processing Charge (APC)?

CNS Neuroscience & Therapeutics is published by Wiley-Blackwell Publishing Ltd. The estimated Article Processing Charge (APC) is approximately $3,599 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of CNS Neuroscience & Therapeutics?

The official ISO-4 abbreviation of CNS Neuroscience & Therapeutics is "CNS NEUROSCI. THER" with common acronym "cnsdr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,861Top JournalHybrid

CNS Neuroscience & Therapeutics

Acronym:cnsdr

•

Abbreviation (ISO):CNS NEUROSCI. THER

•

Identifier (ISSN):1755-5930(Print)/1755-5949(Online)

•

Publisher:Wiley-Blackwell Publishing Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

6.6↑ +1.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for CNS Neuroscience & Therapeutics

WoS Q1

Annual Impact Factor Metric

Current (2026):6.6

Scopus SJR & RankScopus Q1

1.741

#1,861

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

105

105 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate4.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

144articles/year

99.93% Gold OA•84.75% Original Research

Aims & Scope

CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.

Topics Covered (Recognized by AI)

Medicine89.1%Biology82.7%Internal medicine74.2%Psychology69.5%Neuroscience56%Chemistry55.8%Biochemistry52.7%Genetics51.2%Psychiatry49.7%Pathology42.3%Endocrinology40.6%Pharmacology27.8%Physics23.6%Disease23.3%Gene21%Receptor20.9%Immunology20.4%

Primary Research Areas

Medicine Neuroscience

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

NEUROSCIENCES

Rank44/330

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank40/356

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank43/330

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank36/356

IndexSCIE

Category	Index	Rank	Quartile
NEUROSCIENCES	JCRSCIE	44/330	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	40/356	Q1
NEUROSCIENCES	JCISCIE	43/330	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	36/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF6.6

Articles / Year438

Total Citations197

2025

IF5

Articles / Year560

Total Citations2,566

2024

IF4.8

Articles / Year557

Total Citations6,616

2023

IF5.5

Articles / Year503

Total Citations9,096

2022

IF7.035

Articles / Year296

Total Citations6,326

Year	Impact Factor	Articles / Year	Total Citations
2026	6.6	438	197
2025	5	560	2,566
2024	4.8	557	6,616
2023	5.5	503	9,096
2022	7.035	296	6,326
2021	5.243	203	5,079
2020	4.074	143	5,560
2019	3.394	179	7,739
2018	3.495	199	7,297
2017	—	124	4,034
2016	—	162	4,895
2015	—	118	3,981

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,861Scopus Q1SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.741

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.46

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,599 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,240

3-Year Documents1,254

Citable Documents1,199

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1

Pharmacology (medical)Q1

Physiology (medical)Q1

Psychiatry and Mental HealthQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区NEUROSCIENCES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

CNS Neuroscience & Therapeutics (acronym: cnsdr, abbr: CNS NEUROSCI. THER, ISSN: 1755-5930) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in England since 2008. The periodical holds a Journal Impact Factor (JIF) of 6.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.741 (Q1), an H-index of 105.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 144 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,599 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.